Is Senti Biosciences Inc (SNTI) overvalued? · $29.6M cap
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
This page asks whether Senti Biosciences Inc (SNTI) looks expensive on cached numbers — not a short thesis.
Latest reported SNTI revenue for 2024-12-31 was $0. Net income was -$52.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. SNTI currently screens at market cap $29.6M.
SNTI currently screens at market cap $29.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SNTI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SNTI stock page for the full model, not this heading.
Not investment advice.